Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Anticoagulants%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
/vufind/Search/Results?lookfor=%22Anticoagulants%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
Search /vufind/Search2/Results?lookfor=%22Anticoagulants%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
PubPharm (586)
1
Study to gather information about the proper dosing of the oral FXIa inhibitor BAY 2433334 and to compare the safety of the study drug to apixaban, a non-vitamin K oral anticoagulant (NOAC) in patients with irregular heartbeat (atrial fibrillation). : Multicenter, randomized, active comparator-controlled, double-blind, double-dummy, parallel group, dose-finding Phase 2 study to compare the safety of the oral FXIa inhibitor BAY 2433334 to apixaban in patients with atrial fibrillation - PACIFIC-AF
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Reversal of dabigatran anticoagulant effect with idarucizumab. : Single dose, open label, uncontrolled, safety trial of intravenous administration of idarucizumab to paediatric patients enrolled from ongoing phase IIb/III clinical trials with dabigatran etexilate for the treatment and secondary prevention of venous thromboembolism.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Study to gather information about the proper dosing of the oral FXIa inhibitor BAY 2433334 and to compare the safety of the study drug to apixaban, a non-vitamin K oral anticoagulant (NOAC) in patients with irregular heartbeat (atrial fibrillation). : Multicenter, randomized, active comparator-controlled, double-blind, double-dummy, parallel group, dose-finding Phase 2 study to compare the safety of the oral FXIa inhibitor BAY 2433334 to apixaban in patients with atrial fibrillation - PACIFIC-AF
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
Reversal of dabigatran anticoagulant effect with idarucizumab. : Single dose, open label, uncontrolled, safety trial of intravenous administration of idarucizumab to paediatric patients enrolled from ongoing phase IIb/III clinical trials with dabigatran etexilate for the treatment and secondary prevention of venous thromboembolism.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
Use of simplified HAS-BLED score for predicting bleeding events in anticoagulated patients with atrial fibrillation : Use of simplified HAS-BLED score for predicting bleeding events in anticoagulated patients with atrial fibrillation
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
Association between TTR-INR guided warfarin adjustment protocol and time in therapeutic range (TTR) in patients with atrial fibrillation receiving vitamin K antagonist oral anticoagulant : Association between TTR-INR guided warfarin adjustment protocol and time in therapeutic range (TTR) in patients with atrial fibrillation receiving vitamin K antagonist oral anticoagulant
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Revised HAS-BLED score for bleeding prediction in atrial fibrillation patients with oral anticoagulants : Revised HAS-BLED score for bleeding prediction in atrial fibrillation patients with oral anticoagulants
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Effects of a Protocol in a Cellular Application for the prescription of Anticoagulants in the public health system in the city of Ijuí/RS : Evaluation of the Efficacy of a Protocol for patients Anticoagulants of the public health system in the city of Ijuí/RS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
A Cohort of antithrombotic use and Optimal INR Level in patients with non-valvular atrial fibrillation in Thailand. : A Cohort of antithrombotic use and Optimal INR Level in patients with non-valvular atrial fibrillation in Thailand.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
A Randomized Trial of Uninterrupted Warfarin versus Heparin Bridging in Transfemoral Coronary Angiography : A Randomized Trial of Uninterrupted Warfarin versus Heparin Bridging in Transfemoral Coronary Angiography
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[59]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Medienart
586
Aufsätze
586
E-Artikel
586
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
586
610
502
Study Type: Interventional
272
Recruitment Status: Not yet recruiting
120
Phase: Phase 3
112
Recruitment Status: Authorised-recruitment may ...
84
Phase: Phase 4
76
Recruitment Status: Completed
76
Recruitment Status: Recruiting
76
Study Type: Observational
58
Phase: Phase 2
32
Recruitment Status: Complete: follow-up complete
24
Medical Condition: Oral FXa inhibitor-treated p...
20
Medical Condition: Atrial Fibrillation MedDRA v...
18
Medical Condition: Confirmed Venous Thromboembo...
10
Phase: Phase 1
8
Medical Condition: Acquired deficiency of coagu...
8
Medical Condition: Patients with atrial fibrill...
8
Medical Condition: Patients with severe aortic ...
8
Medical Condition: Reversal of vitamin K antago...
8
Medical Condition: regional sodium citrate anti...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
380
2020-
206
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
566
Englisch
10
Unbestimmt
6
Niederländisch
2
Dänisch
2
Finnisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...